Forbion

About

Forbion is a leading venture capital firm that works closely with entrepreneurs to build life sciences companies with technologies and products designed to transform people’s lives.

Forbion currently manages over €1bn across seven closed-end funds, including its €270m Forbion IV fund, launched in 2018, for which Forbion is actively looking for new exciting opportunities. Forbion has a team of ten investment professionals across two offices, in Naarden (NL) and Munich (DE) plus representation in Boston (USA). Forbion’s portfolio companies are developing novel drugs, medical devices and diagnostics for high and unmet medical needs. Besides financial support, Forbion helps companies to bridge research and development through the team’s expertise in drug development and company building.